Cite

HARVARD Citation

    Lu, C. et al. (2017). FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling. Neuroscience letters. pp. 77-83. [Online]. 
  
Back to record